Ethyl bromoacetate → HCID 19357186, compound
Reaction equation
[CH3:1][C:2]1[C:7]([CH3:8])=[CH:6][C:5]([NH:9][C:10]([N:12]2[CH2:17][CH2:16][N:15]([C:18]3[CH:23]=[C:22]([O:24][CH3:25])[CH:21]=[C:20]([O:26][CH3:27])[CH:19]=3)[CH2:14][CH2:13]2)=[O:11])=[C:4]([O:28][CH3:29])[CH:3]=1.[H-].[Na+].Br[CH2:33][C:34]([O:36][CH2:37][CH3:38])=[O:35]>CN(C)C=O>[CH3:27][O:26][C:20]1[CH:19]=[C:18]([N:15]2[CH2:16][CH2:17][N:12]([C:10]([N:9]([CH2:33][C:34]([O:36][CH2:37][CH3:38])=[O:35])[C:5]3[CH:6]=[C:7]([CH3:8])[C:2]([CH3:1])=[CH:3][C:4]=3[O:28][CH3:29])=[O:11])[CH2:13][CH2:14]2)[CH:23]=[C:22]([O:24][CH3:25])[CH:21]=1Participants
5
Reactant 3
Product 1
Reagents, catalysts & solvents 1
Procedure
1-[(4,5-Dimethyl-2-methoxyphenyl)aminocarbonyl]-4-(3,5-dimethoxyphenyl)piperazine(0.2 g, 0.5 mmol) was dissolved in dimethylformamide(15 ml), sodium hydride(18.5 mg, 0.5 mmol) was added thereto, and the resulting mixture was stirred at room temperature. Then, ethyl bromoacetate(83.5 mg, 0.5 mmol) was added thereto and the resulting mixture was stirred for 3 hours, concentrated under the reduced pressure to remove the used solvent and purified by column chromatography(ethylacetate:hexane=1:2) to obtain the titled compound.
Workup
- stirringthe resulting mixture was stirred for 3 hours
- concentrationconcentrated under the reduced pressure
- customto remove the used solvent
- custompurified by column chromatography(ethylacetate:hexane=1:2)
Sources & evidence
- ORD record
- ord-fa00cb69fa364ccfb150246ddb08f584
- Source dataset
- uspto-grants-2000_02
- Patent number
- US06028195
Reaction notes
Loading…